<DOC>
	<DOCNO>NCT02555592</DOCNO>
	<brief_summary>The purpose study identify treatment outcomes surgical resection sequential adjuvant chemotherapy radiotherapy patient stage IIIA non-small cell lung cancer N2 disease sub- para-aortic level .</brief_summary>
	<brief_title>Strategy Surgical Resection With Adjuvant Therapy IIIA NSCLC N2 Disease Only Subaortic Paraaortic Level</brief_title>
	<detailed_description>Stage IIIA non-small cell lung cancer ( NSCLC ) heterogeneous disease current treatment guideline recommend concurrent chemoradiation therapy combine neoadjuvant chemotherapy , surgical resection , sequential adjuvant therapy . When incidental N2 disease find despite thorough preoperative staging , adjuvant platinum-based chemotherapy without adjuvant radiotherapy recommend . Although guideline suggest preoperative mediastinal stag endobronchial ultrasound-guided transbronchial needle aspiration ( EBUS-TBNA ) , method allow approach sub- para-aortic lymph node . Therefore , patient suspect stage IIIA NSCLC N2 disease sub- para-aortic level undergo several process combine neoadjuvant chemotherapy surgical resection plan . First , video-assisted thoracoscopic surgery ( VATS ) perform verify whether sub- para-aortic lymph node involve . If frozen-section biopsy reveals malignant tumor involvement sub- para-aortic lymph node , affect lung resect . If sub- para-aortic lymph node involvement , neoadjuvant chemotherapy require surgical resection adjuvant therapy . Studies show stage IIIA NSCLC sub- para-aortic lymph node involvement well outcomes stage IIIA NSCLC . Moreover , five-year survival patient stage IIIA NSCLC sub- para-aortic lymph node involvement similar stage II NSCLC . However , study retrospective relatively small sample size . Therefore , evaluate outcome combine surgical resection adjuvant chemotherapy radiotherapy patient stage IIIA NSCLC N2 disease sub- para-aortic level .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Patients stage IIIA nonsmall cell lung cancer suspicious N2 disease subaortic paraaortic level , chest CT PET scan Patients whose subaortic paraaortic lymph node reveal negative mediastinal lymph node dissection Patients whose mediastinal lymph node subaortic paraaortic level confirm malignant node mediastinal lymph node dissection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>